1887

Abstract

Hepatitis C virus (HCV) infection often causes extrahepatic manifestations, such as type 2 diabetes. We previously reported that HCV infection induces the lysosomal degradation of the transcription factor HNF-1α via an interaction with viral NS5A, thereby suppressing GLUT2 gene expression. However, the molecular mechanism of NS5A-induced degradation of HNF-1α is largely unknown. We aimed to identify the determinants necessary for the degradation of HNF-1α induced by NS5A. Coimmunoprecipitation analysis revealed that the POU specific (POU) domain spanning from aa 91 to 181 of HNF-1α is responsible for the interaction of NS5A. We also found that the region from aa 121 to 126 of NS5A, which is known as the binding motif of the HCV replication factor FKBP8, is important for the degradation of HNF-1α. A NS5A V121A mutation disrupted the NS5A–HNF-1α interaction as well as the degradation of HNF-1α. Our findings suggest that NS5A Val is crucial for viral pathogenesis.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.000179
2015-08-01
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/8/2200.html?itemId=/content/journal/jgv/10.1099/vir.0.000179&mimeType=html&fmt=ahah

References

  1. Arase Y., Kobayashi M., Suzuki F., Suzuki Y., Kawamura Y., Akuta N., Kobayashi M., Sezaki H., Saito S..otherauthors ( 2013;). Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C. Hepatology 57: 964–973 [CrossRef] [PubMed].
    [Google Scholar]
  2. Blight K.J., McKeating J.A., Marcotrigiano J., Rice C.M.. ( 2003;). Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 77: 3181–3190 [CrossRef] [PubMed].
    [Google Scholar]
  3. Deng L., Shoji I., Ogawa W., Kaneda S., Soga T., Jiang D.P., Ide Y.H., Hotta H.. ( 2011;). Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J Virol 85: 8556–8568 [CrossRef] [PubMed].
    [Google Scholar]
  4. Dong B., Li H., Singh A.B., Cao A., Liu J.. ( 2015;). Inhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1α protein expression through the ubiquitin-proteasome degradation pathway. J Biol Chem 290: 4047–4058 [CrossRef] [PubMed].
    [Google Scholar]
  5. Gao M.. ( 2013;). Antiviral activity and resistance of HCV NS5A replication complex inhibitors. Curr Opin Virol 3: 514–520 [CrossRef] [PubMed].
    [Google Scholar]
  6. Kasai D., Adachi T., Deng L., Nagano-Fujii M., Sada K., Ikeda M., Kato N., Ide Y.H., Shoji I., Hotta H.. ( 2009;). HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters. J Hepatol 50: 883–894 [CrossRef] [PubMed].
    [Google Scholar]
  7. Lai S.W., Chen P.C., Liao K.F., Muo C.H., Lin C.C., Sung F.C.. ( 2012;). Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study. Am J Gastroenterol 107: 46–52 [CrossRef] [PubMed].
    [Google Scholar]
  8. Lindenbach B.D., Evans M.J., Syder A.J., Wölk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R..otherauthors ( 2005;). Complete replication of hepatitis C virus in cell culture. Science 309: 623–626 [CrossRef] [PubMed].
    [Google Scholar]
  9. Love R.A., Brodsky O., Hickey M.J., Wells P.A., Cronin C.N.. ( 2009;). Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus. J Virol 83: 4395–4403 [CrossRef] [PubMed].
    [Google Scholar]
  10. Mason A.L., Lau J.Y., Hoang N., Qian K., Alexander G.J., Xu L., Guo L., Jacob S., Regenstein F.G..otherauthors ( 1999;). Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29: 328–333 [CrossRef] [PubMed].
    [Google Scholar]
  11. Matsui C., Shoji I., Kaneda S., Sianipar I.R., Deng L., Hotta H.. ( 2012;). Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1α. J Virol 86: 12903–12911 [CrossRef] [PubMed].
    [Google Scholar]
  12. Mehta S.H., Brancati F.L., Strathdee S.A., Pankow J.S., Netski D., Coresh J., Szklo M., Thomas D.L.. ( 2003;). Hepatitis C virus infection and incident type 2 diabetes. Hepatology 38: 50–56 [CrossRef] [PubMed].
    [Google Scholar]
  13. Negro F.. ( 2011;). Mechanisms of hepatitis C virus-related insulin resistance. Clin Res Hepatol Gastroenterol 35: 358–363 [CrossRef] [PubMed].
    [Google Scholar]
  14. Negro F., Alaei M.. ( 2009;). Hepatitis C virus and type 2 diabetes. World J Gastroenterol 15: 1537–1547 [CrossRef] [PubMed].
    [Google Scholar]
  15. Okamoto T., Omori H., Kaname Y., Abe T., Nishimura Y., Suzuki T., Miyamura T., Yoshimori T., Moriishi K., Matsuura Y.. ( 2008;). A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication. J Virol 82: 3480–3489 [CrossRef] [PubMed].
    [Google Scholar]
  16. Pawlotsky J.M.. ( 2013;). NS5A inhibitors in the treatment of hepatitis C. J Hepatol 59: 375–382 [CrossRef] [PubMed].
    [Google Scholar]
  17. Ray S.C., Bailey J.R., Thomas D.L.. ( 2013;). Hepatitis C virus. . In Fields’ Virology, 6th edn.., pp. 795–824. Edited by Knipe D. M., Howley P. M.. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins;.
    [Google Scholar]
  18. Shirane M., Nakayama K.I.. ( 2003;). Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol 5: 28–37 [CrossRef] [PubMed].
    [Google Scholar]
  19. Shoji I., Deng L., Hotta H.. ( 2011;). [PubMed] Molecular mechanism of hepatitis C virus-induced glucose metabolic disorders. Front Microbiol 2: (278)
    [Google Scholar]
  20. Tellinghuisen T.L., Marcotrigiano J., Rice C.M.. ( 2005;). Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 435: 374–379 [CrossRef] [PubMed].
    [Google Scholar]
  21. Wang P., Kang D., Cao W., Wang Y., Liu Z.. ( 2012;). Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev 28: 109–122 [CrossRef] [PubMed].
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.000179
Loading
/content/journal/jgv/10.1099/vir.0.000179
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error